10times
17th EditionConference

APASL Single Topic Conference

12 - 14 Dec 2014 New Date Reminder
Baiyun International Convention Center, Guangzhou, China
AboutFollowers 5ReviewsExhibitorsPhotosSpeakersTravel Deals

"Conference with the theme translational medicine clinical immunology and immunotherapy for viral hepatitis"
APASL Single Topic Conference is concentrating recently on the theme of Translational Medicine, Clinical Immunology and Immunotherapy for Viral Hepatitis. The conference is primarily about the discussions of liver diseases which are continuously increasing, including Chronic Hepatitis B, Liver Cirrhosis, Liver Failure and HCC, this wide spread of diseases is driven by two major factors, namely, virological and immunological factors. APASL Single Topic Conference will be looking upon these challenges and unsolved dead ends in clinical immunology of liver diseases which is becoming one of the most popularly discussed topics in gastroenterology and hepatology. The conference throws adequate light on all the concerned aspects of liver diseases.


Timings

01:30 PM - 05:30 PM (Dec 12) (General)
08:30 AM - 07:00 PM (Dec 13) (General)
07:30 AM - 05:00 PM ( Dec 14) (General)
View More

Entry Fees

Paid Ticket Starts from 100 USD View Details

Participants

100 - 500
Delegates
Based on previous editions

Category & Type

Conference
Medical & Pharma

Editions

Dec 2014 17th Edition


Frequency Not Available

Official Links

WebsiteContacts


Report Error
Claim this event
Different Located Editions
Baku, Azerbaijan27 - 28 Jun 2019
9 Followers
Beijing, China06 - 08 Dec 2018
4 Followers
Taipei, Taiwan22 - 24 Jun 2018
2 Followers
Istanbul, Turkey22 - 24 Sep 2016
5 Followers

Organizer

Logo Follow Company

The Asian Pacific Association for the Study of the Liver

China16 Total Events / 2 Upcoming Events

User Community [ Users who have shown interest for this Event ]

Yaser Alahmadi

Yaser Alahmadi

Pharmacist at Moh

Medina, Saudi Arabia
Dr. Harmeet Kaur

Dr. Harmeet Kaur

Jalandhar, India
Polrat Wilairatana

Polrat Wilairatana

Professor at Mahidol University

Bangkok, Thailand
Sandy Liaw

Sandy Liaw

Director at Novira Therapeutics

San Rafael, United States
Dr. Dipendra Raj Pandeya

Dr. Dipendra Raj Pandeya

Asst. Prof at Nepalese Army Institute Of Health Sciences

Kathmandu, Nepal

Write a Review

Add Your Review

Schedule & Agenda

Fri, 12 Dec 01:30 PM - 01:50 PM
POSTGRADUATE COURSE:ELIMINATION OF MOTHER TO INFANT TRANSMISSION OF HEPATITIS B IN THE NEW ERA Course Directors: Hui Zhuang, Ding-Shinn Chen
Perinatal transmission of HBV: prevalence, mechanism and risk factors
Fri, 12 Dec 01:50 PM - 02:10 PM
POSTGRADUATE COURSE:ELIMINATION OF MOTHER TO INFANT TRANSMISSION OF HEPATITIS B IN THE NEW ERA Course Directors: Hui Zhuang, Ding-Shinn Chen
Management of patients with HBV infection planning or have been in pregnancy: East versus West
Fri, 12 Dec 02:10 PM - 02:30 PM
POSTGRADUATE COURSE:ELIMINATION OF MOTHER TO INFANT TRANSMISSION OF HEPATITIS B IN THE NEW ERA Course Directors: Hui Zhuang, Ding-Shinn Chen
Antiretroviral pregnancy registry in US
Fri, 12 Dec 02:30 PM - 02:50 PM
POSTGRADUATE COURSE:ELIMINATION OF MOTHER TO INFANT TRANSMISSION OF HEPATITIS B IN THE NEW ERA Course Directors: Hui Zhuang, Ding-Shinn Chen
Elimination of perinatal transmission of HBV: have we accomplished this goal?
Fri, 12 Dec 02:50 PM - 03:00 PM
POSTGRADUATE COURSE:ELIMINATION OF MOTHER TO INFANT TRANSMISSION OF HEPATITIS B IN THE NEW ERA Course Directors: Hui Zhuang, Ding-Shinn Chen
Panel Discussion
Fri, 12 Dec 03:30 PM - 04:10 PM
OUTSTANDING HEPATOLOGIST FORUM: THE ROAD TO MASTERS OF LIVER DISEASE Course Directors: George Lau, Masao Omata
Eradication of HBV Infection Worldwide and Issues of Immune Tolerance
Fri, 12 Dec 04:10 PM - 04:50 PM
OUTSTANDING HEPATOLOGIST FORUM: THE ROAD TO MASTERS OF LIVER DISEASE Course Directors: George Lau, Masao Omata
My 30-year career in hepatitis B research: looking back and hopes for the future
Fri, 12 Dec 04:50 PM - 05:30 PM
OUTSTANDING HEPATOLOGIST FORUM: THE ROAD TO MASTERS OF LIVER DISEASE Course Directors: George Lau, Masao Omata
How do we evaluate your manuscript?
Sat, 13 Dec 08:30 AM - 09:00 AM
Opening
Sat, 13 Dec 09:00 AM - 09:30 AM
STATE-OF-THE-ART LECTURE:GUIDELINES AND CLINICAL PRACTICE Moderators: Lanjuan Li, Shiv K. Sarin
The process and principles of guideline development: my personal experience
Sat, 13 Dec 09:30 AM - 10:00 AM
STATE-OF-THE-ART LECTURE:GUIDELINES AND CLINICAL PRACTICE Moderators: Lanjuan Li, Shiv K. Sarin
Management of chronic Hepatitis B: Applying guidelines to Clinical Practice
Sat, 13 Dec 10:00 AM - 10:30 AM
STATE-OF-THE-ART LECTURE:GUIDELINES AND CLINICAL PRACTICE Moderators: Lanjuan Li, Shiv K. Sarin
The evidence supporting guideline: contirbution from China
Sat, 13 Dec 11:00 AM - 11:20 AM
OFFICIAL SYMPOSIUM 1 NATURAL HISTORY AND EPIDEMIOLOGY Moderators: Yumei Wen, A Kadir Dokmeci
Prevention of HBV infection and liver cancer: current status and future challenge
Sat, 13 Dec 11:00 AM - 11:20 AM
Venue: Guangdong Hall OFFICIAL SYMPOSIUM 2 CELL-BASED THERAPY FOR LIVER DISEASE Moderators: Jun Cheng, T. Jake Liang
Overview of cell-based therapy: opportunity and chanllenge
Sat, 13 Dec 11:00 AM - 11:20 AM
Venue: Qinghe Hall SPECIAL COURSE 1 HCC and Hepatitis Moderators: Jinlin Hou
Pahogenesis of HBV related HCC
Sat, 13 Dec 11:20 AM - 11:40 AM
Venue: Guangdong Hall OFFICIAL SYMPOSIUM 2 CELL-BASED THERAPY FOR LIVER DISEASE Moderators: Jun Cheng, T. Jake Liang
Immunotherapy of HCC using T cells redirected against HBV
Sat, 13 Dec 11:20 AM - 11:40 AM
Venue: Qinghe Hall SPECIAL COURSE 1 HCC and Hepatitis Moderators: Jinlin Hou
Treatment indication of HCC - medical, surgical or radiation?
Sat, 13 Dec 11:40 AM - 12:00 PM
OFFICIAL SYMPOSIUM 1 NATURAL HISTORY AND EPIDEMIOLOGY Moderators: Yumei Wen, A Kadir Dokmeci
HBV Pre-C/BCP Mutations in Natural History of Chronic HBV Infection
Sat, 13 Dec 11:40 AM - 12:00 PM
Venue: Guangdong Hall OFFICIAL SYMPOSIUM 2 CELL-BASED THERAPY FOR LIVER DISEASE Moderators: Jun Cheng, T. Jake Liang
Standardization of cell-based therapy for liver disease
Sat, 13 Dec 11:40 AM - 12:00 PM
Venue: Qinghe Hall SPECIAL COURSE 1 HCC and Hepatitis Moderators: Jinlin Hou
The latest development of the treatment of HCC
Sat, 13 Dec 12:00 PM - 12:20 PM
OFFICIAL SYMPOSIUM 1 NATURAL HISTORY AND EPIDEMIOLOGY Moderators: Yumei Wen, A Kadir Dokmeci
Risk factors and etiology of liver failure in China
Sat, 13 Dec 12:00 PM - 12:20 PM
Venue: Guangdong Hall OFFICIAL SYMPOSIUM 2 CELL-BASED THERAPY FOR LIVER DISEASE Moderators: Jun Cheng, T. Jake Liang
Immune cell adoptive transfer for HCC therapy
Sat, 13 Dec 12:20 PM - 12:30 PM
OFFICIAL SYMPOSIUM 1 NATURAL HISTORY AND EPIDEMIOLOGY Moderators: Yumei Wen, A Kadir Dokmeci
Discussion
Sat, 13 Dec 12:20 PM - 12:30 PM
Venue: Guangdong Hall OFFICIAL SYMPOSIUM 2 CELL-BASED THERAPY FOR LIVER DISEASE Moderators: Jun Cheng, T. Jake Liang
Discussion
Sat, 13 Dec 12:30 PM - 02:00 PM
LUNCH SYMPOSIUM
Sat, 13 Dec 02:00 PM - 02:20 PM
Venue: Lingnan Hall OFFICIAL SYMPOSIUM 3:IMPACT OF ANTIVIRAL TREATMENT ON DISEASE OUTCOME Moderators: Xinhua Weng, Pietro Lampertico
Reversal of cirrhosis through long-term antiviral therapy: histological evidence
Sat, 13 Dec 02:00 PM - 02:20 PM
Venue: Guangdong Hall OFFICIAL SYMPOSIUM 4: NOVEL PLATFORM FOR DRUG DEVELOPMENT AGAINST HBV INFECTION Moderators: Guiqiang Wang, George K.K. Lau
Experimental models for HBV study and drug development
Sat, 13 Dec 02:00 PM - 02:15 PM
Venue: Qinghe Hall SPECIAL COURSE 2 POLICY AND STRATEGIES FOR THE CONTROL OF HEPATITIS B INFECTION IN ASIAN COUNTRIES Moderators: Hong Ren, Roger S. Williams
Policy and strategies in India
Sat, 13 Dec 02:15 PM - 02:30 PM
Venue: Qinghe Hall SPECIAL COURSE 2 POLICY AND STRATEGIES FOR THE CONTROL OF HEPATITIS B INFECTION IN ASIAN COUNTRIES Moderators: Hong Ren, Roger S. Williams
Policy and strategies in Indonesia
Sat, 13 Dec 02:20 PM - 02:40 PM
Venue: Lingnan Hall OFFICIAL SYMPOSIUM 3:IMPACT OF ANTIVIRAL TREATMENT ON DISEASE OUTCOME Moderators: Xinhua Weng, Pietro Lampertico
How did antiviral therapy change the natural history of chronic hepatitis B?
Sat, 13 Dec 02:20 PM - 02:40 PM
Venue: Guangdong Hall OFFICIAL SYMPOSIUM 4: NOVEL PLATFORM FOR DRUG DEVELOPMENT AGAINST HBV INFECTION Moderators: Guiqiang Wang, George K.K. Lau
Entry inhibitors for the treatment of acute and chronic hepatitis B and hepatitis D virus infections
Sat, 13 Dec 02:30 PM - 02:45 PM
Venue: Qinghe Hall SPECIAL COURSE 2 POLICY AND STRATEGIES FOR THE CONTROL OF HEPATITIS B INFECTION IN ASIAN COUNTRIES Moderators: Hong Ren, Roger S. Williams
Policy and strategies in Mongolia
Sat, 13 Dec 02:40 PM - 03:00 PM
Venue: Lingnan Hall OFFICIAL SYMPOSIUM 3:IMPACT OF ANTIVIRAL TREATMENT ON DISEASE OUTCOME Moderators: Xinhua Weng, Pietro Lampertico
Occurrence of HCC in the era of antiviral therapy: complete elimination or reduction
Sat, 13 Dec 02:40 PM - 03:00 PM
Venue: Guangdong Hall OFFICIAL SYMPOSIUM 4: NOVEL PLATFORM FOR DRUG DEVELOPMENT AGAINST HBV INFECTION Moderators: Guiqiang Wang, George K.K. Lau
Eradication of HBV: can we eliminate cccDNA?
Sat, 13 Dec 02:45 PM - 03:00 PM
Venue: Qinghe Hall SPECIAL COURSE 2 POLICY AND STRATEGIES FOR THE CONTROL OF HEPATITIS B INFECTION IN ASIAN COUNTRIES Moderators: Hong Ren, Roger S. Williams
Policy and strategies in Philippines
Sat, 13 Dec 03:00 PM - 03:20 PM
Venue: Lingnan Hall OFFICIAL SYMPOSIUM 3:IMPACT OF ANTIVIRAL TREATMENT ON DISEASE OUTCOME Moderators: Xinhua Weng, Pietro Lampertico
HBsAg seroclearance after nucleoside analogue therapy in patients with chronic hepatitis B: clinical outcomes and durability
Sat, 13 Dec 03:00 PM - 03:20 PM
Venue: Guangdong Hall OFFICIAL SYMPOSIUM 4: NOVEL PLATFORM FOR DRUG DEVELOPMENT AGAINST HBV INFECTION Moderators: Guiqiang Wang, George K.K. Lau
Target for the design of new antiviral agent
Sat, 13 Dec 03:00 PM - 03:15 PM
Venue: Qinghe Hall SPECIAL COURSE 2 POLICY AND STRATEGIES FOR THE CONTROL OF HEPATITIS B INFECTION IN ASIAN COUNTRIES Moderators: Hong Ren, Roger S. Williams
Policy and strategies in Taiwan
Sat, 13 Dec 03:15 PM - 03:30 PM
Venue: Qinghe Hall SPECIAL COURSE 2 POLICY AND STRATEGIES FOR THE CONTROL OF HEPATITIS B INFECTION IN ASIAN COUNTRIES Moderators: Hong Ren, Roger S. Williams
Policy and strategies in Japan
Sat, 13 Dec 03:20 PM - 03:30 PM
Venue: Lingnan Hall OFFICIAL SYMPOSIUM 3:IMPACT OF ANTIVIRAL TREATMENT ON DISEASE OUTCOME Moderators: Xinhua Weng, Pietro Lampertico
Discussion
Sat, 13 Dec 03:20 PM - 03:30 PM
Venue: Guangdong Hall OFFICIAL SYMPOSIUM 4: NOVEL PLATFORM FOR DRUG DEVELOPMENT AGAINST HBV INFECTION Moderators: Guiqiang Wang, George K.K. Lau
Discussion
Sat, 13 Dec 03:30 PM - 03:45 PM
Venue: Qinghe Hall SPECIAL COURSE 2 POLICY AND STRATEGIES FOR THE CONTROL OF HEPATITIS B INFECTION IN ASIAN COUNTRIES Moderators: Hong Ren, Roger S. Williams
Policy and strategies in Korea
Sat, 13 Dec 03:45 PM - 04:00 PM
Venue: Qinghe Hall SPECIAL COURSE 2 POLICY AND STRATEGIES FOR THE CONTROL OF HEPATITIS B INFECTION IN ASIAN COUNTRIES Moderators: Hong Ren, Roger S. Williams
Policy and strategies in China
Sat, 13 Dec 04:00 PM - 04:20 PM
Venue: Lingnan Hall OFFICIAL SYMPOSIUM 5 CURRENT ANTIVIRAL THERAPY FOR CHRONIC HEPATITIS B Moderators: Jidong Jia, Henry L.Y. Chan
Cure of hepatitis B with antiviral therapy: Reality or not
Sat, 13 Dec 04:00 PM - 05:30 PM
Venue: Guangdong Hall APASL RISING STAR PRESENTATION
Sat, 13 Dec 04:20 PM - 04:40 PM
Venue: Lingnan Hall OFFICIAL SYMPOSIUM 5 CURRENT ANTIVIRAL THERAPY FOR CHRONIC HEPATITIS B Moderators: Jidong Jia, Henry L.Y. Chan
IFN-based optimization strategy for the treatment of chronic hepatitis B
Sat, 13 Dec 04:30 PM - 04:50 PM
Venue: Qinghe Hall SPECIAL COURSE 3 NAFLD and Hepatitis Moderators: Zhongping Duan
NAFLD and Hepatitis B
Sat, 13 Dec 04:40 PM - 05:00 PM
Venue: Lingnan Hall OFFICIAL SYMPOSIUM 5 CURRENT ANTIVIRAL THERAPY FOR CHRONIC HEPATITIS B Moderators: Jidong Jia, Henry L.Y. Chan
NUC- based optimization strategy for the treatment of chronic hepatitis B
Sat, 13 Dec 04:50 PM - 05:10 PM
Venue: Qinghe Hall SPECIAL COURSE 3 NAFLD and Hepatitis Moderators: Zhongping Duan
NAFLD and hepatitis C
Sat, 13 Dec 05:00 PM - 05:20 PM
Venue: Lingnan Hall OFFICIAL SYMPOSIUM 5 CURRENT ANTIVIRAL THERAPY FOR CHRONIC HEPATITIS B Moderators: Jidong Jia, Henry L.Y. Chan
Pathogenesis and treatment of hepatitis B related liver failure
Sat, 13 Dec 05:10 PM - 05:30 PM
Venue: Qinghe Hall SPECIAL COURSE 3 NAFLD and Hepatitis Moderators: Zhongping Duan
NAFLD and non-liver diseases
Sat, 13 Dec 05:20 PM - 05:30 PM
Venue: Lingnan Hall OFFICIAL SYMPOSIUM 5 CURRENT ANTIVIRAL THERAPY FOR CHRONIC HEPATITIS B Moderators: Jidong Jia, Henry L.Y. Chan
Discussion
Sat, 13 Dec 05:30 PM - 07:30 PM
DINNER SYMPOSIUM
Sat, 13 Dec 11:20 PM - 11:40 PM
OFFICIAL SYMPOSIUM 1 NATURAL HISTORY AND EPIDEMIOLOGY Moderators: Yumei Wen, A Kadir Dokmeci
New findings from past decade: What have HBV cohort studies revealed.
Sun, 14 Dec 07:30 AM - 07:50 AM
Venue: Lingnan Hall BREAKFAST WORKSHOP:NEW ERA OF FIBROSIS ASSESMENT Moderators:Qing Xie, Mark Thursz
Quantitative assessment of fibrosis in liver biopsy: from basic to clinical application
Sun, 14 Dec 07:50 AM - 08:10 AM
Venue: Lingnan Hall BREAKFAST WORKSHOP:NEW ERA OF FIBROSIS ASSESMENT Moderators:Qing Xie, Mark Thursz
Non-invasive assessment of liver fibrosis: Can one size fit all?
Sun, 14 Dec 08:10 AM - 08:30 AM
Venue: Lingnan Hall BREAKFAST WORKSHOP:NEW ERA OF FIBROSIS ASSESMENT Moderators:Qing Xie, Mark Thursz
Application of non-invasive tests to clinical practice
Sun, 14 Dec 08:30 AM - 08:50 AM
Venue: Lingnan Hall OFFICIAL SYMPOSIUM 6:MANAGEMENT OF SUBOPTIMAL RESPONDERS AND RESISTANCE Moderators:Xiaoguang Dou, Harry Janssen
New insight into nucleot(s)ide analogues-resistance mechanisms
Sun, 14 Dec 08:30 AM - 08:50 AM
Venue: Guangdong Hall OFFICIAL SYMPOSIUM 7:IMMUNE THERAPEUTIC STRATEGIES IN CHRONIC HBV INFECTION Course Directors: Fusheng Wang, Massimo Levrero
New roles of alum in therapeutic vaccination
Sun, 14 Dec 08:50 AM - 09:10 AM
Venue: Lingnan Hall OFFICIAL SYMPOSIUM 6:MANAGEMENT OF SUBOPTIMAL RESPONDERS AND RESISTANCE Moderators:Xiaoguang Dou, Harry Janssen
Management of suboptimal responders: from clinical trial to clinical practice
Sun, 14 Dec 08:50 AM - 09:10 AM
Venue: Guangdong Hall OFFICIAL SYMPOSIUM 7:IMMUNE THERAPEUTIC STRATEGIES IN CHRONIC HBV INFECTION Course Directors: Fusheng Wang, Massimo Levrero
Immunopathogenesis of chronic HBV infection: whatu2019s New?
Sun, 14 Dec 09:10 AM - 09:30 AM
Venue: Lingnan Hall OFFICIAL SYMPOSIUM 6:MANAGEMENT OF SUBOPTIMAL RESPONDERS AND RESISTANCE Moderators:Xiaoguang Dou, Harry Janssen
Management and Prevention of drug resistance
Sun, 14 Dec 09:10 AM - 09:30 AM
Venue: Guangdong Hall OFFICIAL SYMPOSIUM 7:IMMUNE THERAPEUTIC STRATEGIES IN CHRONIC HBV INFECTION Course Directors: Fusheng Wang, Massimo Levrero
Th cell differentitation and viral infection
Sun, 14 Dec 09:30 AM - 09:50 AM
Venue: Lingnan Hall OFFICIAL SYMPOSIUM 6:MANAGEMENT OF SUBOPTIMAL RESPONDERS AND RESISTANCE Moderators:Xiaoguang Dou, Harry Janssen
Global network for resistance surveillance
Sun, 14 Dec 09:30 AM - 09:50 AM
Venue: Guangdong Hall OFFICIAL SYMPOSIUM 7:IMMUNE THERAPEUTIC STRATEGIES IN CHRONIC HBV INFECTION Course Directors: Fusheng Wang, Massimo Levrero
Targeting innate HBV immunity: TLR agonists
Sun, 14 Dec 09:50 AM - 10:00 AM
Venue: Lingnan Hall OFFICIAL SYMPOSIUM 6:MANAGEMENT OF SUBOPTIMAL RESPONDERS AND RESISTANCE Moderators:Xiaoguang Dou, Harry Janssen
Discussion
Sun, 14 Dec 09:50 AM - 10:00 AM
Venue: Guangdong Hall OFFICIAL SYMPOSIUM 7:IMMUNE THERAPEUTIC STRATEGIES IN CHRONIC HBV INFECTION Course Directors: Fusheng Wang, Massimo Levrero
Discussion
Sun, 14 Dec 10:30 AM - 10:50 AM
Venue: Lingnan Hall OFFICIAL SYMPOSIUM 8:REVISITING THE TREATMENT RECOMMENDATION BY GUIDELINES Moderators: Lai Wei, Jia-Horng Kao
Do guidelines preclude hepatitis B patients from receiving treatment?
Sun, 14 Dec 10:30 AM - 10:50 AM
Venue: Guangdong Hall OFFICIAL SYMPOSIUM 9:HEPATOCELLULAR CARCINOMA AND GENETICS Moderators: Yuming Wang, Dong Jin Suh
Genetic study of liver diseases
Sun, 14 Dec 10:50 AM - 11:10 AM
Venue: Lingnan Hall OFFICIAL SYMPOSIUM 8:REVISITING THE TREATMENT RECOMMENDATION BY GUIDELINES Moderators: Lai Wei, Jia-Horng Kao
What evidence to support antiviral therapy in children?
Sun, 14 Dec 10:50 AM - 11:10 AM
Venue: Guangdong Hall OFFICIAL SYMPOSIUM 9:HEPATOCELLULAR CARCINOMA AND GENETICS Moderators: Yuming Wang, Dong Jin Suh
GWAS study in HBV infection
Sun, 14 Dec 11:10 AM - 11:30 AM
Venue: Lingnan Hall OFFICIAL SYMPOSIUM 8:REVISITING THE TREATMENT RECOMMENDATION BY GUIDELINES Moderators: Lai Wei, Jia-Horng Kao
Therapy for immune tolerant hepatitis B: our next target population?
Sun, 14 Dec 11:10 AM - 11:30 AM
Venue: Guangdong Hall OFFICIAL SYMPOSIUM 9:HEPATOCELLULAR CARCINOMA AND GENETICS Moderators: Yuming Wang, Dong Jin Suh
Mechanism of HBV related HCC
Sun, 14 Dec 11:30 AM - 11:50 AM
Venue: Lingnan Hall OFFICIAL SYMPOSIUM 8:REVISITING THE TREATMENT RECOMMENDATION BY GUIDELINES Moderators: Lai Wei, Jia-Horng Kao
What is missing in APASL guideline
Sun, 14 Dec 11:30 AM - 11:50 AM
Venue: Guangdong Hall OFFICIAL SYMPOSIUM 9:HEPATOCELLULAR CARCINOMA AND GENETICS Moderators: Yuming Wang, Dong Jin Suh
Role of HBV integration in the pathogenesis of hepatocellular carcinoma
Sun, 14 Dec 11:50 AM - 12:00 PM
Venue: Lingnan Hall OFFICIAL SYMPOSIUM 8:REVISITING THE TREATMENT RECOMMENDATION BY GUIDELINES Moderators: Lai Wei, Jia-Horng Kao
Discussion
Sun, 14 Dec 11:50 AM - 12:00 PM
Venue: Guangdong Hall OFFICIAL SYMPOSIUM 9:HEPATOCELLULAR CARCINOMA AND GENETICS Moderators: Yuming Wang, Dong Jin Suh
Discussion
Sun, 14 Dec 12:00 PM - 01:30 PM
LUNCH SYMPOSIUM
Sun, 14 Dec 01:30 PM - 01:50 PM
Venue: Lingnan Hall OFFICIAL SYMPOSIUM 10:-ANTIVIRAL TREATMENT IN SPECIAL POPULATION Moderators: Fengmin Lu, Stephen Locarnini
Update on the management of immune suppressed patients
Sun, 14 Dec 01:30 PM - 01:50 PM
Venue: Guandgong Hall OFFICIAL SYMPOSIUM 11:STRATEGIES OF STOPPING TREATMENT Moderators: Zhiliang Gao, Teerha Pirativisuth
Is it possible to achieve sustained off-treatment response by switching NUC to IFN
Sun, 14 Dec 01:50 PM - 02:10 PM
Venue: Lingnan Hall OFFICIAL SYMPOSIUM 10:-ANTIVIRAL TREATMENT IN SPECIAL POPULATION Moderators: Fengmin Lu, Stephen Locarnini
Coinfection of HBV and HIV
Sun, 14 Dec 01:50 PM - 02:10 PM
Venue: Guandgong Hall OFFICIAL SYMPOSIUM 11:STRATEGIES OF STOPPING TREATMENT Moderators: Zhiliang Gao, Teerha Pirativisuth
Revising the stopping rule of guideline recommendation for NUC-treated patients
Sun, 14 Dec 02:10 PM - 02:30 PM
Venue: Lingnan Hall OFFICIAL SYMPOSIUM 10:-ANTIVIRAL TREATMENT IN SPECIAL POPULATION Moderators: Fengmin Lu, Stephen Locarnini
Role of peginterferon plus ribavirin in the current regime of hepatitis C therapy in Asia-Pacific area?
Sun, 14 Dec 02:10 PM - 02:30 PM
Venue: Guandgong Hall OFFICIAL SYMPOSIUM 11:STRATEGIES OF STOPPING TREATMENT Moderators: Zhiliang Gao, Teerha Pirativisuth
Stopping rules for patients treated with IFN
Sun, 14 Dec 02:30 PM - 02:50 PM
Venue: Lingnan Hall OFFICIAL SYMPOSIUM 10:-ANTIVIRAL TREATMENT IN SPECIAL POPULATION Moderators: Fengmin Lu, Stephen Locarnini
The role of DAA in the treatment of chronic hepatitis C: WEST versus EAST
Sun, 14 Dec 02:30 PM - 02:50 PM
Venue: Guandgong Hall OFFICIAL SYMPOSIUM 11:STRATEGIES OF STOPPING TREATMENT Moderators: Zhiliang Gao, Teerha Pirativisuth
Stopping treatment: a practical and unmet medical need in Asia
Sun, 14 Dec 02:50 PM - 03:00 PM
Venue: Lingnan Hall OFFICIAL SYMPOSIUM 10:-ANTIVIRAL TREATMENT IN SPECIAL POPULATION Moderators: Fengmin Lu, Stephen Locarnini
Discussion
Sun, 14 Dec 02:50 PM - 03:00 PM
Venue: Guandgong Hall OFFICIAL SYMPOSIUM 11:STRATEGIES OF STOPPING TREATMENT Moderators: Zhiliang Gao, Teerha Pirativisuth
Discussion
Sun, 14 Dec 03:30 PM - 03:50 PM
Venue: Lingnan Hall OFFICIAL SYMPOSIUM 12:PERSPECTIVE FOR THE TREATMENT OF CHRONIC HEPATITIS B IN THE COMING DECADES Course Directors: Zhenghong Yuan, Stephan Urban
Sun, 14 Dec 03:30 PM - 05:00 PM
ORAL PRESENTATION
Sun, 14 Dec 03:50 PM - 04:10 PM
Venue: Lingnan Hall OFFICIAL SYMPOSIUM 12:PERSPECTIVE FOR THE TREATMENT OF CHRONIC HEPATITIS B IN THE COMING DECADES Course Directors: Zhenghong Yuan, Stephan Urban
Ongoing preclinical and clinical studies: New compound, New future
Sun, 14 Dec 04:10 PM - 04:30 PM
Venue: Lingnan Hall OFFICIAL SYMPOSIUM 12:PERSPECTIVE FOR THE TREATMENT OF CHRONIC HEPATITIS B IN THE COMING DECADES Course Directors: Zhenghong Yuan, Stephan Urban
HBV DNA suppression versus HBsAg seroclearance versus reduction of cccDNA as endpoint
Sun, 14 Dec 04:30 PM - 04:50 PM
Venue: Lingnan Hall OFFICIAL SYMPOSIUM 12:PERSPECTIVE FOR THE TREATMENT OF CHRONIC HEPATITIS B IN THE COMING DECADES Course Directors: Zhenghong Yuan, Stephan Urban
New biomarkers for efficacy prediction : new wine in old bottle
Sun, 14 Dec 04:50 PM - 05:00 PM
Venue: Lingnan Hall OFFICIAL SYMPOSIUM 12:PERSPECTIVE FOR THE TREATMENT OF CHRONIC HEPATITIS B IN THE COMING DECADES Course Directors: Zhenghong Yuan, Stephan Urban
Discussion

Visitor Ticket Price

Group Registration (Ten people or more)
220 USDEarly Registration(2014-11-28)
300 USDOnsite
Accompanying Person
250 USDEarly Registration(2014-11-28)
340 USDOnsite
Trainee/Residents
100 USDEarly Registration(2014-11-28)
150 USDOnsite
Delegates
250 USDEarly Registration(2014-11-28)
340 USDOnsite
APASL Member
170 USDEarly Registration(2014-11-28)
250 USDOnsite
23.186962113.278520

Venue Map & Directions

map of Baiyun International Convention Center

Baiyun International Convention Center

1039-1045 Baiyun S Ave BaiYun YinShi WenHua ChangLang Baiyun Qu Guangzhou Shi Guangdong Sheng 510405
China

Get Directions

Featured Hotels in Guangzhou

More Hotels